SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-100764
Filing Date
2021-08-05
Accepted
2021-08-05 16:16:24
Documents
48
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q enzn-20210630x10q.htm   iXBRL 10-Q 647494
2 EXHIBIT 31.1 enzn-20210630xex31d1.htm EX-31.1 13635
3 EXHIBIT 32.1 enzn-20210630xex32d1.htm EX-32.1 6849
  Complete submission text file 0001104659-21-100764.txt   2557432

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA enzn-20210630.xsd EX-101.SCH 28193
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20210630_cal.xml EX-101.CAL 15144
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20210630_def.xml EX-101.DEF 69430
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20210630_lab.xml EX-101.LAB 173340
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20210630_pre.xml EX-101.PRE 150702
9 EXTRACTED XBRL INSTANCE DOCUMENT enzn-20210630x10q_htm.xml XML 289447
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12957 | Film No.: 211148413
SIC: 2836 Biological Products, (No Diagnostic Substances)